Cargando…
Heparin‐induced thrombocytopenia in end‐stage renal disease: Reliability of the PF4‐heparin ELISA
BACKGROUND: Diagnosing heparin‐induced thrombocytopenia (HIT) in patients with end‐stage renal disease (ESRD) can be difficult, as they are frequently exposed to heparin and have multiple etiologies for thrombocytopenia. OBJECTIVE: To correlate 4T scores, IgG heparin–platelet factor 4 (PF4‐heparin)...
Autores principales: | Kelly, Julie, Sylvester, Katelyn W., Rimsans, Jessica, Bernier, Thomas D., Ting, Clara, Connors, Jean M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339384/ https://www.ncbi.nlm.nih.gov/pubmed/34386689 http://dx.doi.org/10.1002/rth2.12573 |
Ejemplares similares
-
Evaluation of Antifactor-Xa Heparin Assay and Activated Partial
Thromboplastin Time Values in Patients on Therapeutic Continuous Infusion Unfractionated
Heparin Therapy
por: McLaughlin, Kevin, et al.
Publicado: (2019) -
Heparin-Induced Thrombocytopenia in Healthy Individuals with Continuous Heparin Infusion
por: Williams, Jonathan S., et al.
Publicado: (2018) -
Emphasis on the Role of PF4 in the Incidence, Pathophysiology and Treatment of Heparin Induced Thrombocytopenia
por: Prechel, M Margaret, et al.
Publicado: (2013) -
Heparin: Heparin-induced thrombocytopenia: case report
Publicado: (2020) -
Heparin: Heparin-induced thrombocytopenia : case report
Publicado: (2020)